JIVE 📈 JPMorgan International Value - Overview
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • • Foreign Large Value
JIVE: Stocks, Foreign Companies, Subsidiaries, Developed Markets, Emerging Markets
The fund invests primarily in equity securities and equity-related instruments of foreign companies, including foreign subsidiaries of U.S. companies. The fund may invest in issuers located in both developed foreign and emerging market countries. Developed foreign countries include Australia, Canada, Israel, Japan, New Zealand, Singapore, the United Kingdom, most of the countries of Western Europe and Hong Kong; emerging market countries include most of the other countries in the world.
Additional Sources for JIVE ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
JIVE ETF Overview
| Market Cap in USD | 107m |
| Category | Foreign Large Value |
| TER | 0.55% |
| IPO / Inception | 2023-09-13 |
JIVE ETF Ratings
| Growth 5y | 62.3% |
| Fundamental | - |
| Dividend | 52.8% |
| Rel. Strength Industry | -15.3 |
| Analysts | - |
| Fair Price Momentum | 50.40 USD |
| Fair Price DCF | - |
JIVE Dividends
| Dividend Yield 12m | 2.51% |
| Yield on Cost 5y | 2.91% |
| Annual Growth 5y | 90.74% |
| Payout Consistency | 100.0% |
JIVE Growth Ratios
| Growth Correlation 3m | -68.3% |
| Growth Correlation 12m | 79.2% |
| Growth Correlation 5y | 90.6% |
| CAGR 5y | 11.66% |
| CAGR/Mean DD 5y | 5.09 |
| Sharpe Ratio 12m | 0.52 |
| Alpha | -5.00 |
| Beta | 0.60 |
| Volatility | 12.86% |
| Current Volume | 2.8k |
| Average Volume 20d | 12.8k |
What is the price of JIVE stocks?
As of January 15, 2025, the stock is trading at USD 54.50 with a total of 2,800 shares traded.
Over the past week, the price has changed by -2.17%, over one month by -3.48%, over three months by -6.27% and over the past year by +12.81%.
As of January 15, 2025, the stock is trading at USD 54.50 with a total of 2,800 shares traded.
Over the past week, the price has changed by -2.17%, over one month by -3.48%, over three months by -6.27% and over the past year by +12.81%.
Is JPMorgan International Value a good stock to buy?
Yes. Based on ValueRay Analyses, JPMorgan International Value (NASDAQ:JIVE) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.32 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JIVE as of January 2025 is 50.40. This means that JIVE is currently overvalued and has a potential downside of -7.52%.
Yes. Based on ValueRay Analyses, JPMorgan International Value (NASDAQ:JIVE) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.32 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JIVE as of January 2025 is 50.40. This means that JIVE is currently overvalued and has a potential downside of -7.52%.
Is JIVE a buy, sell or hold?
JPMorgan International Value has no consensus analysts rating.
JPMorgan International Value has no consensus analysts rating.
What are the forecast for JIVE stock price target?
According to ValueRays Forecast Model, JIVE JPMorgan International Value will be worth about 55.3 in January 2026. The stock is currently trading at 54.50. This means that the stock has a potential upside of +1.49%.
According to ValueRays Forecast Model, JIVE JPMorgan International Value will be worth about 55.3 in January 2026. The stock is currently trading at 54.50. This means that the stock has a potential upside of +1.49%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 55.3 | 1.5% |